PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.

scientific article

PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1050226578
P356DOI10.1038/SJ.ONC.1203151
P698PubMed publication ID10602505
P5875ResearchGate publication ID12697974

P50authorJesus M. ParamioQ43100805
Manuel NavarroQ47159759
Elena Gómez-Casero EstebanQ73283414
P2093author name stringJ L Jorcano
C Segrelles
P2860cites workRapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stabilityQ42829486
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in miceQ58378937
Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2FQ73925270
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphateQ24317714
Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTENQ24322051
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphataseQ24322705
The retinoblastoma protein and cell cycle controlQ27860722
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancerQ27860985
Inhibition of cell proliferation by p107, a relative of the retinoblastoma proteinQ28260016
Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiationQ28283261
Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2/INK4AQ28289708
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersQ28306997
Pten is essential for embryonic development and tumour suppressionQ28509238
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTENQ28513537
Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zetaQ28582003
An Essential Role for Rho, Rac, and Cdc42 GTPases in Cell Cycle Progression Through G 1Q29614256
Regulation of retinoblastoma protein functions by ectopic expression of human cyclinsQ29618320
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transductionQ29618388
Rho Family GTPases Bind to Phosphoinositide KinasesQ33292549
PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cellsQ33586807
The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathwayQ33599964
3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitroQ34452063
The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factorsQ35769059
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1Q36234063
Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathwaysQ36256326
Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinasesQ36646526
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domainQ36818855
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell linesQ37537138
Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathwaysQ38354870
Modulation of cell proliferation by cytokeratins K10 and K16Q39445342
Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformationQ39576120
Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblastsQ39610954
Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinaseQ40020874
p53 and Rb: their cellular rolesQ40606655
Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K.Q41075804
The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1.Q42812980
Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.Q42824933
Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1.Q42827718
P433issue52
P407language of work or nameEnglishQ1860
P921main subjectretinoblastomaQ500695
P304page(s)7462-7468
P577publication date1999-12-01
P1433published inOncogeneQ1568657
P1476titlePTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
P478volume18

Reverse relations

cites work (P2860)
Q351280093-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex
Q34649053A Dictyostelium secreted factor requires a PTEN-like phosphatase to slow proliferation and induce chemorepulsion
Q36386230A novel tumor suppressor network in squamous malignancies
Q24310760Activation of p53 by MEG3 non-coding RNA
Q35232272Autophagy regulation in cancer development and therapy
Q49923280C33-A cells transfected with E6*I or E6*II the short forms of HPV-16 E6, displayed opposite effects on cisplatin-induced apoptosis.
Q74688995CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast
Q30440601Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis
Q39365401Cell Cycle Control by PTEN.
Q40615729Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop.
Q39658846ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma
Q34583094Effects and mechanisms of silibinin on human hepatoma cell lines
Q35842249Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas
Q40757135Functional roles of Akt signaling in mouse skin tumorigenesis.
Q38142173Genomic Rearrangements of PTEN in Prostate Cancer
Q93079092Highlights in Resistance Mechanism Pathways for Combination Therapy
Q43977582Hypoosmotic stress stimulates growth in HepG2 cells via protein kinase B-dependent activation of activator protein-1.
Q37704701Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes
Q34073864Identification of myelin transcription factor 1 (MyT1) as a subunit of the neural cell type-specific lysine-specific demethylase 1 (LSD1) complex.
Q24548285Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest
Q34047231Integrin-linked kinase (ILK): a "hot" therapeutic target
Q42628891Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage
Q27851755Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era.
Q34283477Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.
Q46772716Molecular determinants of Akt-induced keratinocyte transformation
Q34533889Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10)
Q38384489Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment
Q28587617Nuclear receptor TLX prevents retinal dystrophy and recruits the corepressor atrophin1
Q58134027Over-expression of PTEN on proliferation and apoptosis in canine mammary tumors cells
Q34180652PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench
Q35661819PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.
Q34796595PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium
Q54674580PTEN promoter methylation and protein expression in normal early placentas and hydatidiform moles.
Q37270432PTEN: a new guardian of the genome.
Q38871799Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias.
Q37431908Phosphatase and tensin homologue on chromosome 10 (PTEN) directs prostaglandin E2-mediated fibroblast responses via regulation of E prostanoid 2 receptor expression
Q34135631Phosphatidylinositol 3-kinases in tumor progression
Q24613810Protean PTEN: form and function
Q34707865Pten signaling in gliomas
Q27933247Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast
Q43825785Regulation of the differentiation-related gene Drg-1 during mouse skin carcinogenesis
Q36727409Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression
Q38175052Skin Tumors Rb(eing) Uncovered.
Q34825957The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network
Q34229795The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
Q35970384The Rho Guanine Nucleotide Exchange Factor DRhoGEF2 Is a Genetic Modifier of the PI3K Pathway in Drosophila
Q36002446The elements of human cyclin D1 promoter and regulation involved
Q42518511The expression of keratin k10 in the basal layer of the epidermis inhibits cell proliferation and prevents skin tumorigenesis
Q33849727The multiple roles of PTEN in tumor suppression
Q37454384The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.

Search more.